Role of patient factors and practice patterns in determining access to liver waitlist

American Journal of Transplantation

Volumn 15, Issue 7, 2015, Pages 1836-1842

  Adler, J T ^a,b   Dong, N ^b   Markmann, J F ^b,c   Schoenfeld, D ^d   Yeh, H ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Donors and donation: deceased; patient referral

Indexed keywords

SODIUM;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEATH CERTIFICATE; END STAGE LIVER DISEASE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH CARE PRACTICE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PATIENT HISTORY OF TRANSPLANTATION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; CLINICAL PRACTICE; DONOR; FOLLOW UP; HEALTH CARE DELIVERY; LIVER DISEASES; MORTALITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK FACTOR; SUPPLY AND DISTRIBUTION; SURVIVAL RATE; TRANSPLANTATION; UTILIZATION;

AGED; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PRACTICE PATTERNS, PHYSICIANS'; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS;

EID: 84931577222     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13301     Document Type: Article

References (18)

1. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR,. Underestimation of liver-related mortality in the United States. Gastroenterology 2013; 145: 375-382.
2. Scientific Regsitry of Transplant Recipients. 2012. Annual data report. Available from: http://srtr.transplant.hrsa.gov/annual-reports/2012/Default.aspx.
3. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ,. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 1003-1019.
4. Mathur AK, Ashby VB, Fuller DS, et al., Variation in access to the liver transplant waiting list in the United States. Transplantation 2014; 98: 94-99.
5. Axelrod DA, Guidinger MK, Finlayson S, et al., Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008; 299: 202-207.
6. Tuttle-Newhall JE, Rutledge R, Johnson M, Fair J,. A statewide, population-based, time series analysis of access to liver transplantation. Transplantation 1997; 63: 255-262.
7. Yeh H, Smoot E, Schoenfeld DA, Markmann JF,. Geographic inequity in access to livers for transplantation. Transplantation 2011; 91: 479-486.
8. Boulware LE, Troll MU, Wang NY, Powe NR,. Perceived transparency and fairness of the organ allocation system and willingness to donate organs: A national study. Am J Transplant 2007; 7: 1778-1787.
9. US Census Bureau. Population estimates: Intercensal estimates. Available from: http://www.census.gov/popest/data/intercensal/.
10. Liang K-Y, Zeger SL,. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
11. Feng S, Goodrich NP, Bragg-Gresham JL, et al., Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
12. Halldorson JB, Paarsch HJ, Dodge JL, Segre AM, Lai J, Roberts JP,. Center competition and outcomes following liver transplantation. Liver Transpl 2012; 19: 96-104.
13. Maluf DG, Edwards EB, Kauffman HM,. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation 2006; 82: 1653-1657.
14. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA,. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313.
15. Percy C, Stanek E, Gloeckler L,. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 242-250.
16. Selikoff IJ,. Use of death certificates in epidemiological studies, including occupational hazards: Discordance with clinical and autopsy findings. Am J Ind Med 1992; 22: 469-480.
17. Hinchliffe SR, Abrams KR, Lambert PC,. The impact of under and over-recording of cancer on death certificates in a competing risks analysis: A simulation study. Cancer Epidemiol 2013; 37: 11-19.
18. Adler JT, Sethi RKV, Yeh H, Markmann JF, Nguyen LL,. Market competition influences renal transplantation risk and outcomes. Ann Surg 2014; 260: 550-557.